Global Markets
Novo Nordisk (NOVOB DC) says Wegovy resulted in a BMI reduction of 10% or more in almost 80% of children aged 6-12
ORIGINAL · NewsquawkNovo Nordisk (NOVOB DC) says Wegovy resulted in a BMI reduction of 10% or more in almost 80% of children aged 6-12
StockNow breaking-news AI analysis
Novo Nordisk reported substantial BMI reductions among children aged 6-12, as detailed results from the phase III STEP Young study were scheduled for presentation in November.
Related stocks
1 stocksWhat do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
